Back
Nektar Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
NKTR
Nektar Therapeutics
Last Price:
$46.82
Seasonality Move:
6.44%
7 Day Trial
ALL ACCESS PASS
$
7
Nektar Therapeutics Stock Forecast
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 24.9% based on the past 31 years of stock performance.
-
Nektar Therapeutics has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
-
Is Nektar Therapeutics Stock Undervalued?The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Nektar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 24.9% based on the past 31 years of stock performance.
Nektar Therapeutics Stock Rating
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics overpriced?
-
Nektar Therapeutics has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
Nektar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com
52-Week Data
52-Week High:
66.92
52-Week Low:
6.48
Prediction Charts
Market Cap:
810.4M
Price in USD:
46.84
Volume:
1M
Beta:
1.25
Technical Analysis
SMA50:
57.37
SMA100:
48.86
SMA200:
31.53
52-Wk Change:
231.85%
Stock Predictions
-
Is Nektar Therapeutics stock public?Yes, Nektar Therapeutics is a publicly traded company.
-
What is the Nektar Therapeutics stock quote today?The Nektar Therapeutics stock price is 46.84 USD today.
-
How to buy Nektar Therapeutics stock online?You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 61.11 | 54.85 | 61.40 | 54.65 |
| Dec-3 | 55.00 | 57.13 | 57.37 | 53.55 |
| Dec-4 | 56.90 | 57.69 | 57.86 | 54.75 |
| Dec-5 | 57.99 | 56.90 | 58.10 | 55.67 |
| Dec-8 | 57.83 | 57.28 | 58.94 | 56.54 |
| Dec-9 | 57.08 | 58.78 | 59.23 | 56.01 |
| Dec-10 | 58.17 | 57.74 | 58.99 | 56.70 |
| Dec-11 | 57.33 | 51.12 | 57.90 | 51.04 |
| Dec-12 | 51.27 | 54.70 | 56.99 | 51.26 |
| Dec-15 | 54.01 | 53.30 | 54.20 | 52.01 |
| Dec-16 | 48.68 | 49.16 | 52.50 | 45.25 |
| Dec-17 | 50.08 | 45.43 | 51.47 | 44.34 |
| Dec-18 | 45.57 | 44.00 | 46.89 | 42.62 |
| Dec-19 | 44.10 | 46.84 | 47.12 | 43.62 |
Nektar Therapeutics Earnings
Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Nektar Therapeutics Forecast Revenue Growth
Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.